After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process. The Pune-based firm was, however, directed to take extra precautions. Effectively, the order directing SII to stop recruitment of candidates was also withdrawn.

source https://www.newsbytesapp.com/timeline/india/66102/311765/sii-gets-approval-to-resume-vaccine-trial